Fractionation Parameters for Human Tissues and Tumors

References

• Barendsen G.W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. International Journal of Radiation Oncology, Biology and Physics 1982; 8: 1981–1999
   PubMed Web of Science ®Google Scholar
• Bennett M.R. The treatment of Stage III squamous carcinoma of the cervix in air and hyperbaric oxygen. British Journal of Radiology 1978; 51: 68–68
   Web of Science ®Google Scholar
• Bentzen, S.M., Overgaard, M., Thames, H.D. Fractionation sensitivity of a functional endpoint: impaired shoulder movement after post-mastectomy radio-therapy. International Journal of Radiation Oncology, Biology and Physics, in press, 1989a
   Web of Science ®Google Scholar
• Bentzen S.M., Thames H.D., Overgaard M. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiotherapy and Oncology 1989b; 15: 267–274
   PubMed Web of Science ®Google Scholar
• Bentzen, S.M., Overgaard, J., Thames, H.D., Overgaard, M., Vejby-Hansen, P., van der Maase, H., Mader, J. Clinical radiobiology of malignant melanoma. Radiotherapy and Oncology, in press, 1989c
   Web of Science ®Google Scholar
• Bogaert W., van den. Ph.D. thesis. Catholic University, LeuvenBelgium 1982
   Google Scholar
• Budihna M., Skrk J., Smid L., Furlan L. Tumour cell repopulation in the rest interval of split-course radiation treatment. Strahlentherapie 1980; 156: 402–408
   PubMedGoogle Scholar
• Byhardt R.W., Greenberg M., Cox J.D. Local control of squamous carcinoma of oral cavity and oropharynx with 3 vs. 5 treatment fractions per week. International Journal of Radiation Oncology, Biology and Physics 1977; 2: 415–420
   PubMed Web of Science ®Google Scholar
• Cox J.D. Presidential Address: Fractionation: A paradigm for clinical research in radiation oncology. International Journal of Radiation Oncology, Biology and Physics 1987; 13: 1271–1281
   PubMed Web of Science ®Google Scholar
• Dische S., Martin W.M.C., Anderson P. Radiation myelopathy in patients treated for carcinoma of bronchus using a six fraction regime of radiotherapy. British Journal of Radiology 1981; 54: 29–35
   PubMed Web of Science ®Google Scholar
• Edsmyr F., Andersson L., Espoti P.L., Littbrand B., Nilsson B. Irradiation therapy with multiple small fractions per day in urinary bladder cancer. Radiotherapy and Oncology 1985; 4: 197–203
   PubMed Web of Science ®Google Scholar
• Fletcher G.H., MacComb W.S., Shalek R.J. Radiation Therapy in the Management of Cancer of the Oral Cavity and Oropharynx (monograph). Charles C. Thomas, Springfield, IL 1962
   Google Scholar
• Fletcher G.H., Barkley H.T., Shukovsky L.J. Present status of the time factor in clinical radiotherapy. II. the nominal standard dose formula. Journal de Radiologie et de l'Electrologie 1974; 55: 745–751
   Google Scholar
• Fowler J.F. Dose-response curves for organ function or cell survival. British Journal of Radiology 1983; 56: 497–500
   PubMed Web of Science ®Google Scholar
• Handa K., Edoliya T.N., Pandey R.K., Agarwal Y.C., Sinha N.A. A radiotherapeutic clinical trial of twice per week vs five times per week in oral cancer. Strahlentherapie 1980; 156: 626–631
   PubMedGoogle Scholar
• Harrison D., Crennan E., Cruickshank D., Hughes P., Ball D. Hypofractionation reduces the therapeutic ratio in early glottic carcinoma. International Journal Radiation Oncology, Biology and Physics 1988; 15: 365–372
   PubMed Web of Science ®Google Scholar
• Henk J.M., James K.W. Comparative trial of large and small fractions in the radiotherapy of head and neck cancer. Clinical Radiology 1978; 29: 611–616
   PubMed Web of Science ®Google Scholar
• Holsti L.R. An introduction to unconventional fractionation: Clinical experiences and future indications (Excluding MFD). Proceedings Varian's 4th European Cliac Users Meeting, Malta. Zug, Varian 1984
   Google Scholar
• Holsti L.R., Salmo M. Split-course radiotherapy of the larynx: ten year results of a randomized study. UICC Conference on Clinical Oncology, Lausanne, 1981, Abstract 04-0335
   Google Scholar
• Horiot J.-C., Fletcher G.H., Ballantyne A.J., Lindberg R.D. Analysis of failures in early vocal cord cancer. Radiology 1972; 103: 663–665
   PubMed Web of Science ®Google Scholar
• Horiot J., van den Bogaert W., Ang K.K., van der Schueren E., Bartelink H., Gonzalez D., de Pauw M., van Glabbeke M. European Organization for Research on Treatment of Cancer Trials Using Radiotherapy with Multiple Fractions per Day. A 1978–1987 survey. Time, Dose and Fractionation in the Radiation Therapy of Cancer, Vol. 22 of Frontiers of Radiation Therapy and Oncology, J.M. Vaeth, Meyer. Karger, Basel 1988; 149–161
   Google Scholar
• van Limbergen E., Rijnders A., van der Schueren E., Lernt T., Christiaens R. Cosmetic evaluation of breast conserving treatment for mammary cancer. II. The influence of radiation dose, fractionation schedules and treatment techniques on cosmetic results after tumor excision and radiotherapy. A quantitative analysis. International Journal of Radiation Oncology, Biology and Physics 1989, (submitted)
   Google Scholar
• Maciejewski B., Preuss-Bayer G., Trott K.-R. The influence of the number of fractions and of overall time on local control and late complications rate in squamous cell carcinoma of the larynx. International Journal of Radiation Oncology, Biology and Physics 1983; 9: 321–328
   PubMed Web of Science ®Google Scholar
• Maciejewski B., Taylor J.M.B., Withers H.R. Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx. Radiotherapy and Oncology 1986; 7: 323–326
   PubMed Web of Science ®Google Scholar
• Marcial V., Pajak T., Chang C., Tupchong L., Stetz J. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality. Preliminary report by the Radiation Therapy Oncology Group (RTOG). International Journal of Radiation Oncology, Biology and Physics 1987; 13: 41–47
   PubMed Web of Science ®Google Scholar
• Overgaard J., Overgaard M., Vejby Hansen P., von der Maase H. Some factors of importance in the radiation treatment of malignant melanoma. Radiotherapy and Oncology 1986; 5: 183–192
   PubMed Web of Science ®Google Scholar
• Overgaard J., Hjelm-Hansen M., Vendelbo Johansen L., Andersen A.P. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncologica 1988; 27: 147–152
   PubMed Web of Science ®Google Scholar
• Overgaard M., Bentzen S.M., Juul Christensen J., Hjollund Madsen E. The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. Radiotherapy and Oncology 1987; 9: 1–12
   PubMed Web of Science ®Google Scholar
• Reitan J.B., Kaalhus O. Radiotherapy of liposarcomas. British Journal of Radiology 1980; 53: 969–975
   PubMed Web of Science ®Google Scholar
• Stell P.M., Morrison M.D. Radiation necrosis of the larynx. Archives of Otolaryngology 1973; 98: 111–113
   PubMedGoogle Scholar
• Thames H.D. An ‘incomplete-repair’ model for survival after fractionated and continuous irradiations. International Journal of Radiation Biology 1985; 47: 319–339
   Web of Science ®Google Scholar
• Thames H.D., Hendry J.H. Fractionation in Radiotherapy. Taylor & Francis, London 1987
   Google Scholar
• Thames H.D., Suit H.D. Tumor radioresponsiveness versus fractionation sensitivity. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 687–691
   PubMed Web of Science ®Google Scholar
• Thames H.D., Withers H.R., Peters L.J., Fletcher G.H. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. International Journal of Radiation Oncology, Biology and Physics 1982; 8: 219–226
   PubMed Web of Science ®Google Scholar
• Thames H.D., Peters L.J., Withers H.R., Fletcher G.H. Accelerated fractionation vs. Hyperfractionation: rationales for several treatments per day. International Journal of Radiation Oncology, Biology and Physics 1983; 9: 127–138
   PubMed Web of Science ®Google Scholar
• Thames H.D., Withers H.R., Peters L.J. Tissue repair capacity and repair kinetics deduced from multifractionated or continuous irradiation regimens with incomplete repair. British Journal of Cancer 1984; 49(Suppl. VI)263–269
   PubMed Web of Science ®Google Scholar
• Thames H.D., Rozell M.E., Tucker S.L., Ang K.K., Fisher D.R., Travis E.L. Direct analysis of quantal radiation response data. International Journal of Radiation Biology 1986; 49: 999–1009
   Web of Science ®Google Scholar
• Thames H.D., Peters L.J., Ang K.K. Time-dose considerations for normal-tissue tolerance. Frontiers of Radiation Therapy and Oncology, J.M. Vaeth, 1989a; 23, in press
   Google Scholar
• Thames H.D., Bentzen S.M., Turesson I., Overgaard M., van den Bogaert W. Time-dose factors in radiotherapy: a review of the human data. Radiotherapy and Oncology 1989b, (submitted)
   Web of Science ®Google Scholar
• Trott K.R., von Lieven H., Kummermehr J., Skopal D., Lukacs S., Braun-Falco O., Kellerer A.M. The radiosensitivity of malignant melanomas. Part II: Clinical studies. International Journal of Radiation Oncology, Biology and Physics 1981; 7: 15–20
   PubMed Web of Science ®Google Scholar
• Trott K.R., Maciejewski B., Preuss-Bayer G. Dose-response curve and split-dose recovery in human skin cancer. Radiotherapy and Oncology 1984; 2: 123–130
   PubMed Web of Science ®Google Scholar
• Turesson I., Notter G. Control of dose administered once a week and three times a day according to schedules calculated by the CRE formula, using skin reaction as a biological parameter. Radiology 1976; 120: 399–404
   PubMed Web of Science ®Google Scholar
• Turesson I., Notter G. The influence of the overall treatment time in radiotherapy on the acute reaction: comparison of the effects on daily and twice-a-week fractionation on human skin. International Journal of Radiation Oncology, Biology and Physics 1984; 10: 607–619
   PubMed Web of Science ®Google Scholar
• Turesson I., Thames H.D. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 years' follow-up. Radiotherapy and Oncology 1989; 15: 169–188
   PubMed Web of Science ®Google Scholar
• Watson E.R., Halnan K.E., Dische S., Saunders M.I., Cade I., McEwen J.B., Wiernik G., Perrins D.J.D., Sutherland I. Hyperbaric oxygen and radiotherapy: A Medical Research Council trial in carcinoma of the cervix. British Journal of Radiology 1978; 51: 879–887
   PubMed Web of Science ®Google Scholar
• Williams M.V., Denekamp J., Fowler J.F. A review of α/β values for experimental tumors: implications for clinical studies of altered fractionation. International Journal of Radiation Oncology, Biology and Physics 1985; 11: 87–96
   PubMed Web of Science ®Google Scholar
• Withers H.R., Taylor J.M.G., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncologica 1988; 27: 131–146
   PubMed Web of Science ®Google Scholar